To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 July 2025 to Question 67568 on Obesity: Drugs, whether his Department has issued any guidance to the public on the risks of obtaining weight loss medications through on
The Medicines and Healthcare products Regulatory Agency (MHRA) continually monitors the safety of all medicines, including weight loss drugs such as GLP-1 receptor agonists (GLP-1 RAs).Patient safety is our top priority, and no medicine would be approved ...
Obesity: Drugs